Methodological approaches to the prevention of preeclampsia in high-risk pregnant women in perinatal practice
DOI:
https://doi.org/10.15574/PP.2026.1(105).119124Keywords:
preeclampsia, pathophysiology, high-risk group, perinatal consequences, early diagnosis, prevention, methodological recommendationsAbstract
Preeclampsia is one of the most common and severe complications of pregnancy, which makes a significant contribution to the structure of maternal and perinatal morbidity and mortality. Despite the improvement of clinical protocols for pregnancy management, the frequency of severe forms of preeclampsia remains consistently high, especially among high-risk pregnant women.
Aim - to substantiate and systematize modern methodological approaches to the prevention of preeclampsia in high-risk pregnant women for their implementation in the practice of perinatal institutions.
This study was based on the analysis of international clinical recommendations (FIGO, ACOG, NICE), national pregnancy management protocols, as well as the results of randomized clinical trials and meta-analyses published in leading professional publications over the past 10 years. The methods of systematic analysis, generalization and expert assessment were applied. Based on the analysis of international and national recommendations, a step-by-step algorithm of preventive measures is proposed, which is aimed at the early identification of risk groups, optimization of drug and non-drug prevention, as well as the reduction of adverse perinatal outcomes.
Conclusions. The proposed methodological approaches to the prevention of preeclampsia in high-risk pregnant women of high risk contribute to reducing the frequency of severe forms of the disease and improving perinatal outcomes. Early identification of risk factors and step-by-step prevention is an integral part of modern perinatal care.
The authors declare that there is no conflict of interest.
References
ACOG. (2020). Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 135(6): e237-e260. https://doi.org/10.1097/AOG.0000000000003891; PMid:32443079 PMCid:PMC8907436
Bartsch E, Medcalf KE, Park AL, Ray JG et al. (2016). Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review. BMJ. 353: i1753. https://doi.org/10.1136/bmj.i1753; PMid:27094586 PMCid:PMC4837230
Browna MA, Mageec LA, Kennyd LC, Karumanchie SA, McCarthyf FP, Saitog Sh et al. (2018). The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Hypertension. 72(1): 24-43. https://doi.org/10.1161/HYPERTENSIONAHA.117.10803; PMid:29899139
Burton GJ, Redman CW, Roberts JM et al. (2019). Pre-eclampsia: pathophysiology and clinical implications. BMJ. 366: l2381. https://doi.org/10.1136/bmj.l2381; PMid:31307997 PMCid:PMC12042644
Chaemsaithong P, Sahota DS, Poon LC. (2022., Feb). First trimester preeclampsia screening and prediction. Am J Obstet Gynecol. 226; 2 Suppl: S1071-S1097.e2. https://doi.org/10.1016/j.ajog.2020.07.020; PMid:32682859
Chappell LC, Cluver CA, Kingdom J, Tong S. (2021). Pre-eclampsia. Lancet. 398(10297): 341-354. https://doi.org/10.1016/S0140-6736(20)32335-7; PMid:34051884
Dimitriadis E, Rolnik DL, Zhou W et al. (2023). Pre-eclampsia. Nat Rev Dis Primers. 9(1): 8. https://doi.org/10.1038/s41572-023-00417-6; PMid:36797292
Fisher JJ, Bartho LA, Perkins AV, Holland OJ. (2020). Placental mitochondria and reactive oxygen species in the physiology and pathophysiology of pregnancy. Clin. Exp. Pharmacol. Physiol. 47: 176-184. https://doi.org/10.1111/1440-1681.13172; PMid:31469913
Gangi FE, Faramarzi M, Bouzari Z, Khafri S, Bazgir MR, Netadj M. (2025, Aug 6). Psychological Distress and Maternal Outcomes in Women With Pre-eclampsia: A Retrospective Case-Control Study. Health Sci Rep. 8(8): e71133. https://doi.org/10.1002/hsr2.71133; PMid:40772116 PMCid:PMC12326432
Garovic VD, Dechend R, Easterling T et al. (2022). Hypertension in Pregnancy: A Scientific Statement From the American Heart Association. Hypertension. 79(2): e21-e41. https://doi.org/10.1161/HYP.0000000000000208; PMid:34905954 PMCid:PMC9031058
Gathiram P, Moodley J. (2016). Pre-eclampsia: pathogenesis and pathophysiology. Cardiovasc J Afr. 27(2): 71-78. https://doi.org/10.5830/CVJA-2016-009; PMid:27213853 PMCid:PMC4928171
Jahan F, Vasam G, Green AE, Bainbridge SA, Menzies KJ. (2023, Feb 20). Placental Mitochondrial Function and Dysfunction in Preeclampsia. Int J Mol Sci. 24(4): 4177. https://doi.org/10.3390/ijms24044177; PMid:36835587 PMCid:PMC9963167
Karumanchi SA. (2016, Jun). Angiogenic Factors in Preeclampsia: From Diagnosis to Therapy. Hypertension. 67(6): 1072-1079. https://doi.org/10.1161/HYPERTENSIONAHA.116.06421; PMid:27067718
Khashan AS, Evans M, Kublickas M, McCarthy FP, Kenny LC, Stenvinkel P et al. (2019, Jul 30). Preeclampsia and risk of end stage kidney disease: A Swedish nationwide cohort study. PLoS Med. 16(7): e1002875. https://doi.org/10.1371/journal.pmed.1002875; PMid:31361741 PMCid:PMC6667103
Magee LA, Nicolaides KH, von Dadelszen P. (2022). Preeclampsia. N Engl J Med. 386(19): 1817-1832. https://doi.org/10.1056/NEJMra2109523; PMid:35544388
Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A et al. (2023). 2023 ESH Guidelines for the management of arterial hypertension. J Hypertens. 41(12): 1874-2071. doi: 10.1097/HJH.0000000000003480. Erratum in: J Hypertens. 2024 Jan 1;42(1):194. https://doi.org/10.1097/HJH.0000000000003621; PMid:38033262 PMCid:PMC12680807
Martell Claros N, Asenjo de la Fuente JE, Abad Cardiel M, García Donaire JA, Herráiz MA. (2020, Apr-Jun). Role of the renin-angiotensin system in pregnancy and preeclampsia. Hipertens Riesgo Vasc. 37(2): 72-77. https://doi.org/10.1016/j.hipert.2020.02.003; PMid:32147515
Michalczyk M, Celewicz A, Celewicz M, Woźniakowska-Gondek P, Rzepka R. (2020, Oct 5). The Role of Inflammation in the Pathogenesis of Preeclampsia. Mediators Inflamm. 2020: 3864941. https://doi.org/10.1155/2020/3864941; PMid:33082708 PMCid:PMC7556088
Montgomery KS, Hensley C, Winseman A, Marshall C, Robles A. (2024, Nov). A Systematic Review of Complications Following Pre-eclampsia. Matern Child Health J. 28(11): 1876-1885. https://doi.org/10.1007/s10995-024-03999-z; PMid:39316252
MOZ Ukrainy. (2022). Pro zatverdzhennia standartiv medychnoi dopomohy «Normalna vahitnist». Nakaz MOZ Ukrainy vid 09.08.2022 № 152.
MOZ Ukrainy. (2022). Unifikovanyi klinichnyi protokol pervynnoi, vtorynnoi (spetsializovanoi) ta tretynnoi (vysokospetsializovanoi) medychnoi dopomohy «Hipertenzyvni rozlady pid chas vahitnosti, polohiv ta u pisliapolohovomu periodi». Nakaz MOZ Ukrainy vid 24 sichnia 2022 roku № 151.
O'Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, de Alvarado M et al. (2017, Jun). Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol. 49(6): 756-760. doi: 10.1002/uog.17455. Erratum in: Ultrasound Obstet Gynecol. 2017 Dec; 50(6): 807. https://doi.org/10.1002/uog.18950; PMCid:PMC12127726
Papamichail M, Fasoulakis Z, Daskalakis G, Theodora M, Rodolakis A, Antsaklis P. (2022, Nov 8). Importance of Low Pregnancy Associated Plasma Protein-A (PAPP-A) Levels During the First Trimester as a Predicting Factor for Adverse Pregnancy Outcomes: A Prospective Cohort Study of 2636 Pregnant Women. Cureus. 14(11): e31256. https://doi.org/10.7759/cureus.31256
Petca A, Miron BC, Pacu I, Dumitrașcu MC, Mehedințu C, Șandru F et al. (2022, Feb 21). HELLP Syndrome-Holistic Insight into Pathophysiology. Medicina (Kaunas). 58(2): 326. https://doi.org/10.3390/medicina58020326; PMid:35208649 PMCid:PMC8875732
Phipps EA, Thadhani R, Benzing T, Karumanchi SA. (2019). Pre-eclampsia: pathogenesis and diagnostics. Nat Rev Nephrol. 15(5): 275-289. https://doi.org/10.1038/s41581-019-0119-6; PMid:30792480 PMCid:PMC6472952
Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H et al. (2019). The FIGO initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 145; Suppl 1: 1-33. https://doi.org/10.1002/ijgo.12802; PMid:31111484 PMCid:PMC6944283
Puttaiah A, Kirthan JPA, Sadanandan DM, Somannavar MS. (2024, Jul). Inflammatory markers and their association with preeclampsia among pregnant women: A systematic review and meta-analysis. Clin Biochem. 129: 110778. https://doi.org/10.1016/j.clinbiochem.2024.110778; PMid:38876455
Rana S, Lemoine E, Granger JP, Karumanchi SA. (2019). Preeclampsia: Pathophysiology and Perspectives. Circ Res. 124(7): 1094-1112. https://doi.org/10.1161/CIRCRESAHA.118.313276; PMid:30920918 PMCid:PMC12042644
Ridder A, Giorgione V, Khalil A, Thilaganathan B. (2019). Preeclampsia: the relationship between uterine artery blood flow and trophoblast function. Int J Mol Sci. 20(13): 3263. https://doi.org/10.3390/ijms20133263; PMid:31269775 PMCid:PMC6651116
Roberge S, Bujold E, Nicolaides KH. (2018, Mar). Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol. 218(3): 287-293.e1. https://doi.org/10.1016/j.ajog.2017.11.561; PMid:29138036
Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, de Paco Matallana C et al. (2017). Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia (ASPRE). N Engl J Med. 377(7): 613-622. https://doi.org/10.1056/NEJMoa1704559; PMid:28657417
Sato Y, Fujiwara H, Konishi I. (2012). Mechanism of maternal vascular remodeling during human pregnancy. Reprod Med Biol. 11(1): 27-36. https://doi.org/10.1007/s12522-011-0102-9; PMid:29699103 PMCid:PMC5906868
Scott G, Gillon TE, Pels A, von Dadelszen P, Magee LA. (2022, Feb). Guidelines-similarities and dissimilarities: a systematic review of international clinical practice guidelines for pregnancy hypertension. Am J Obstet Gynecol. 226(2S): S1222-S1236. https://doi.org/10.1016/j.ajog.2020.08.018; PMid:32828743
Staff AC. (2019). The two-stage placental model of preeclampsia: an update. J Reprod Immunol. 134-135: 1-10. https://doi.org/10.1016/j.jri.2019.07.004; PMid:31301487 PMCid:PMC12042644
Stevens W, Shih T, Incerti D, Ton TGN, Lee HC, Peneva D et al. (2017). Short-term costs of preeclampsia in the US. Am J Obstet Gynecol. 217(3): 237-248. https://doi.org/10.1016/j.ajog.2017.04.032; PMid:28708975
Tan MY, Syngelaki A, Poon LC, Rolnik DL, O'Gorman N, Delgado JL et al. (2018, Aug). Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation. Ultrasound Obstet Gynecol. 52(2): 186-195. https://doi.org/10.1002/uog.19112; PMid:29896812
Tzanaki I, Makrigiannakis A, Lymperopoulou C, Al-Jazrawi Z, Agouridis AP. (2025). Pregnancy-associated plasma protein A (PAPP-A) as a first trimester serum biomarker for preeclampsia screening: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 38(1): 2448502. https://doi.org/10.1080/14767058.2024.2448502; PMid:39757003
Trent AR, Parry JW, Yokley JE, Grathwohl KW. (2022, Mar 30). Posterior Reversible Encephalopathy Syndrome and Pre-eclampsia/Eclampsia: Anesthetic Implications and Management. Cureus. 14(3): e23659. https://doi.org/10.7759/cureus.23659
USPSTF; Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB et al. (2021, Sep 28). Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services Task Force Recommendation Statement. JAMA. 326(12): 1186-1191. doi: 10.1001/jama.2021.14781. Erratum in: JAMA. 2026 May 12; 335(18): 1640. https://doi.org/10.1001/jama.2025.20680
Valenzuela FJ, Pérez-Sepúlveda A, Torres MJ, Correa P, Repetto GM, Illanes SE. (2012). Pathogenesis of preeclampsia: the genetic component. J Pregnancy. 2012: 632732. https://doi.org/10.1155/2012/632732; PMid:22175024 PMCid:PMC3235819
Xie E, Tao H, Liu M, Li C, Zhao Q. (2022, Aug 15). The effect of exercise on the prevention of gestational hypertension in obese and overweight pregnant women: An updated meta-analysis. Front Public Health. 10: 923161. https://doi.org/10.3389/fpubh.2022.923161; PMid:36045739 PMCid:PMC9420989
Yang H, Ai M, Guo Y, Li B, Liu C, Qu D. (2023, May 24). NLRP3 inflammasome in peripheral blood monocytes as a risk factor for early -onset preeclampsia. BMC Pregnancy Childbirth. 23(1): 380. https://doi.org/10.1186/s12884-023-05606-5; PMid:37226086 PMCid:PMC10207815
Zhang Y, Yang H, Zhang Y, Shi J, Long Y. (2022, Sep). A Novel Circular RNA CircBRAP May Be Used as an Early Predictor of Preeclampsia and Its Potential Mechanism. Reprod Sci. 29(9): 2565-2579. https://doi.org/10.1007/s43032-022-00842-0; PMid:35015290
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Ukrainian Journal of Perinatology and Pediatrics
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “Ukrainian Journal of Perinatology and Pediatrics” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license(СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
